PFIZER |
Precio de cierre
Otros sitios de cotización
|
||
| - | - |
|
Resumen de negocios
- productos de atención primaria (72,8%): medicamentos utilizados en medicina interna, vacunas, medicamentos para la prevención y el tratamiento de la Covid-19, antivirales, productos a base de ARNm, etc.;
- productos de atención especializada (13,8%): medicamentos utilizados en inmunología, en hospitales y para el tratamiento de enfermedades raras, antiinflamatorios, etc;
- productos oncológicos (12,1%);
- otros (1,3%).
A finales de 2022, el grupo contaba con más de 35 centros de fabricación en todo el mundo.
Las ventas netas se distribuyen geográficamente del siguiente modo: Estados Unidos (42,3%), Europa (21,9%) y otros (35,8%).
Ventas por actividad
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
Biopharma
97,8
%
| 98 988 | 98,7 % | 57 186 | 97,8 % | -42,23 % |
Other Business Activities
2,2
%
| 1 342 | 1,3 % | 1 310 | 2,2 % | -2,38 % |
Ventas por región
| USD en millones | 2022 | Peso | 2023 | Peso | Delta |
|---|---|---|---|---|---|
United States
46,3
%
| 42 473 | 42,3 % | 27 088 | 46,3 % | -36,22 % |
Emerging Markets
20,5
%
| 20 097 | 20,0 % | 11 996 | 20,5 % | -40,31 % |
Developed Europe
19,9
%
| 21 982 | 21,9 % | 11 650 | 19,9 % | -47,00 % |
Developed Rest of World
7,3
%
| 7 752 | 7,7 % | 4 251 | 7,3 % | -45,16 % |
Japan
6,0
%
| 8 026 | 8,0 % | 3 510 | 6,0 % | -56,27 % |
Directores
| Directores | Puesto | Edad | Desde |
|---|---|---|---|
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/01/93 |
David Denton
DFI | Director of Finance/CFO | 59 | 02/05/22 |
Jeff Settleman
CTO | Chief Tech/Sci/R&D Officer | - | 01/07/19 |
| Chief Tech/Sci/R&D Officer | - | 01/01/07 | |
Maria Rivas
CTO | Chief Tech/Sci/R&D Officer | 60 | 01/09/22 |
Aida Habtezion
CTO | Chief Tech/Sci/R&D Officer | - | 01/01/21 |
Rady Johnson
CMP | Compliance Officer | 63 | 01/01/94 |
Lidia Fonseca
CTO | Chief Tech/Sci/R&D Officer | 55 | - |
Mikael Dolsten
CTO | Chief Tech/Sci/R&D Officer | 65 | 01/10/09 |
| Investor Relations Contact | - | 19/07/21 |
Administradores
| Administradores | Puesto | Edad | Desde |
|---|---|---|---|
| Director/Board Member | 66 | 01/04/20 | |
Ronald Blaylock
BRD | Director/Board Member | 64 | 23/02/17 |
Shantanu Narayen
BRD | Director/Board Member | 60 | 27/09/13 |
Susan Hockfield
BRD | Director/Board Member | 73 | 04/03/20 |
Suzanne Johnson
BRD | Director/Board Member | 66 | 01/09/07 |
Scott Gottlieb
BRD | Director/Board Member | 51 | 27/06/19 |
Jim Smith
BRD | Director/Board Member | 64 | 26/06/14 |
James Quincey
BRD | Director/Board Member | 59 | 27/02/20 |
| Director/Board Member | 66 | 25/06/15 | |
Albert Bourla
CEO | Chief Executive Officer | 62 | 01/01/93 |
Clase de acciones
| Vote | Quantity | Flotante | Autocontrol | Total Float | |
|---|---|---|---|---|---|
| Acción A | 1 | 9 591 592 898 | 5 663 767 188 ( 59,05 %) | 3 925 000 000 ( 40,92 %) | 59,05 % |
Participaciones
| Nombre | Acciones | % | Valoración |
|---|---|---|---|
HALEON PLC 32.36% | 2 955 063 626 | 32.36% | 12 231 510 709 $ |
PFIZER LIMITED 63.92% | 29 243 042 | 63.92% | 1 611 461 224 $ |
| 27 349 211 | 15.01% | 1 114 206 856 $ | |
ARVINAS, INC. 5.05% | 3 457 815 | 5.05% | 114 591 989 $ |
ALLOGENE THERAPEUTICS, INC. 10.55% | 22 032 040 | 10.55% | 55 080 100 $ |
AKERO THERAPEUTICS, INC. 3.65% | 2 525 252 | 3.65% | 47 525 243 $ |
VALNEVA 6.86% | 9 549 761 | 6.86% | 42 650 761 $ |
PYXIS ONCOLOGY, INC. 11.94% | 7 032 770 | 11.94% | 26 302 560 $ |
PYXIS ONCOLOGY, INC. 4.96% | 1 272 214 | 4.96% | 17 518 387 $ |
NXERA PHARMA CO., LTD. 2.10% | 1 885 136 | 2.10% | 17 418 412 $ |
Información de la empresa
Empresas del grupo
| Nombre | Categoría y sector |
|---|---|
Wyeth Holdings LLC
 Wyeth Holdings LLC Chemicals: AgriculturalProcess Industries Wyeth Holdings LLC manufactures and distributes chemicals. The firm's chemical contains phosphate rock, calcium, lime, carbide and nitrogen which are used in fertilizers. The company was founded by Frank Washburn in 1907 and is headquartered in Wayne, NJ. |
Chemicals: Agricultural
|
Genetics Institute LLC
 Genetics Institute LLC Pharmaceuticals: MajorHealth Technology Genetics Institute LLC develops pharmaceutical products through recombinant DNA and other genetic technologies. It develops drugs to make the blood of hemophiliacs clot, as well as substances that stimulate the production of red and white blood cells and proteins that enhance bone growth. The company was founded in 1980 and is headquartered in Cambridge, MA. |
Pharmaceuticals: Major
|
Wyeth Pharmaceuticals LLC
 Wyeth Pharmaceuticals LLC Pharmaceuticals: MajorHealth Technology Wyeth Pharmaceuticals LLC develops pharmaceutical, biotechnology and vaccine technologies. The company was registered on May 5, 2003 and is headquartered in Collegeville, PA. |
Pharmaceuticals: Major
|
Thiakis Ltd.
 Thiakis Ltd. Pharmaceuticals: MajorHealth Technology Thiakis Ltd. develops hormone-based treatments for obesity and other metabolic diseases. It focuses to commercialize an effective anti-obesity treatment based on a peptide hormone called oxyntomodulin. The company was founded in 2004 by Steve Bloom and John Burt and is headquartered in Sandwich, the United Kingdom. |
Pharmaceuticals: Major
|
Pharmaceuticals: Major
| |
Pfizer Manufacturing Ireland Unlimited Co.
 Pfizer Manufacturing Ireland Unlimited Co. Pharmaceuticals: MajorHealth Technology Pfizer Manufacturing Ireland manufactures and exports pharmaceutical products. It offers formulation and manufacture of human pharmaceuticals and animal health care products. Its Dublin plant manufactures sterile pharmaceutical products. The company was founded in 1969 and is headquartered in Dublin, Ireland. |
Pharmaceuticals: Major
|
Wyeth Consumer Healthcare, Inc.
 Wyeth Consumer Healthcare, Inc. Pharmaceuticals: MajorHealth Technology Wyeth Consumer Healthcare, Inc. discovers, develops and manufactures health care products. The company is headquartered in Mississauga, Canada. |
Pharmaceuticals: Major
|
Ferrosan ApS
 Ferrosan ApS Pharmaceuticals: OtherHealth Technology Ferrosan ApS manufactures and sells pharmaceutical products. Its products include herbal medicine, natural remedies, food supplements, and medical devices. The company was founded by Niels Jacob Herman Weitzmann in 1920 and is headquartered in Ballerup, Denmark. |
Pharmaceuticals: Other
|
John Wyeth & Brother Ltd.
 John Wyeth & Brother Ltd. Pharmaceuticals: MajorHealth Technology John Wyeth & Bros Ltd. manufactures pharmaceutical products. Its products include protein therapeutics, the rheumatoid arthritis treatment Enbrel, the influenza vaccines Begrivac, and Agrippal medications for depression, hemophilia, cancer and bacterial infections. The company was founded in 1960 by John Wyeth and is headquartered in Taplow, the United Kingdom. |
Pharmaceuticals: Major
|
Ventas por actividad
Ventas por región
| Varia. 1 de ene. | Capi. | |
|---|---|---|
| +54,63 % | 815 mil M | |
| +44,25 % | 654 mil M | |
| -6,51 % | 354 mil M | |
| +22,12 % | 337 mil M | |
| +10,56 % | 302 mil M | |
| +18,45 % | 247 mil M | |
| +2,09 % | 229 mil M | |
| +13,03 % | 219 mil M | |
| +9,35 % | 171 mil M |
- Bolsa de valores
- Acciones
- Acción PFE
- Acción PFZ
- Empresa PFIZER
